Healthcare
THC Biomed Intl Ltd.(THCBF)
Live Price
Offline$0.001
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 16, 2026
- Market Cap
- —
- Revenue Growth
- -35.1%
- EPS Growth
- +51.9%
- Dividend Yield
- 0.0%
Coverage: 247 bars · Jun 23, 2025 → Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
THC Biomed Intl Ltd. (THCBF) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 16, 2026). Baseline metrics include revenue growth of -35.1%, EPS growth of +51.9%, a dividend yield of 0.0%. What stands out right now is revenue -35.1%, EPS +51.9%, free cash flow -43.8% with operating margin -95.9% and ROIC -28.0%. Valuation is more restrained than many high-expectation growth names at price/sales 1.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines THCBF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-35.1% vs +7.6% peer median
Operating Margin
Below sector median
-95.9% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
The operating picture looks softer than before
Revenue is at -35.1% and EPS is at +51.9%, with operating margin around -95.9%.
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
THCBF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
THCBF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for THCBF and SPY.
Company Overview
THC Biomed Intl Ltd.
Other OTC
THC Biomed Intl Ltd. produces and sells medical and recreational cannabis in Canada. It offers cannabis beverage shots, gummies, and biscuits under the THC KISS brand names, as well as pure cannabis sticks. The company was founded in 2012 and is headquartered in Kelowna, Canada.
- Leadership
- John Miller
- IPO Date
- Mar 16, 2018
- Employees
- 35
- Street Address
- 2550 Acland Road
- Mailing
- Kelowna, BC, V1X 7L4
- Region
- Kelowna, BC, CA
- Reporting Currency
- USD
- Investor Line
- +1 844 842 6337
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- —
- EV/EBITDA
- —
- Price/Sales
- 1.0
- Price/Book
- 0.5
Growth
- Revenue
- -35.1%
- EPS
- +51.9%
- Free Cash Flow
- -43.8%
Profitability
- Gross Margin
- -30.8%
- Operating Margin
- -95.9%
- Net Margin
- -91.8%
- ROE
- -36.7%
- ROIC
- -28.0%
Balance Sheet
- Debt/Equity
- 0.65
- Current Ratio
- 0.63
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.